Direct autocrine action of insulin on β-cells: Does it make physiological sense?

Diabetes

Volumn 62, Issue 7, 2013, Pages 2157-2163

  Rhodes, Christopher J ^a   White, Morris F ^b   Leahy, John L ^c   Kahn, Steven E ^d  

^a University of Chicago ^*  (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Diabetes and Metabolism   (United States)

^d Division of Metabolism Endocrinology and Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR;

AUTOCRINE EFFECT; CELL FUNCTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; HUMAN; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84883687796     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0246     Document Type: Review

References (64)

1. Goldfine AB, Kulkarni RN. Modulation of β-cell function: A translationaljourney from the bench to the bedside. Diabetes Obes Metab 2012;14(Suppl. 3):152-160
2. Leibiger IB, Leibiger B, Berggren P-O. Insulin signaling in the pancreaticβ-cell. Annu Rev Nutr 2008;28:233-251
3. Kulkarni RN. Insulin action in the islet β-cell. In Mechanisms of InsulinAction. 1st ed. Saltiel A, Pessin J, Eds. Austin, Landes Bioscience and Springer Science+Business Media, 2007, p. 133-151
4. White MF. Regulating insulin signaling and beta-cell function through IRS proteins. Can J Physiol Pharmacol 2006;84:725-737
5. Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998;391:900-904
6. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999;23:32-40
7. Kubota N, Tobe K, Terauchi Y, et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000;49:1880-1889
8. Rhodes CJ. Type 2 diabetes-a matter of β-cell life and death? Science 2005; 307:380-384
9. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005;36: 197-209
10. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846
11. Demozay D, Tsunekawa S, Briaud I, Shah R, Rhodes CJ. Specific glucoseinduced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells. Diabetes 2011;60:2892-2902
12. Jhala US, Canettieri G, Screaton RA, et al. cAMP promotes pancreatic betacell survival via CREB-mediated induction of IRS2. Genes Dev 2003;17: 1575-1580
13. Lingohr MK, Briaud I, Dickson LM, et al. Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet beta-cells. J Biol Chem 2006;281:15884-15892
14. Cheng Z, Tseng Y, White MF. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab 2010;21:589-598
15. Tsunekawa S, Demozay D, Briaud I, et al. FoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytes. Diabetes 2011;60:2883-2891
16. Briaud I, Dickson LM, Lingohr MK, McCuaig JF, Lawrence JC, Rhodes CJ. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 2005;280:2282-2293
17. Awazawa M, Ueki K, Inabe K, et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL- 6-dependent pathway. Cell Metab 2011;13:401-412
18. Zick Y. Ser/Thr phosphorylation of IRS proteins: A molecular basis for insulin resistance. Sci STKE 2005;2005:pe4
19. Carpentier JL, Fehlmann M, Van Obberghen E, Gorden P, Orci L. Insulin receptor internalization and recycling: mechanism and significance. Biochimie 1985;67:1143-1145
20. Heaton JH, Gelehrter TD. Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism. J Biol Chem 1981;256: 12257-12262
21. Schulz B, Doberne L, Greenfield M, Reaven GM. Insulin receptor binding and insulin-mediated glucose uptake in type-II-diabetics. Exp Clin Endocrinol 1983;81:49-58
22. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 2000;85:4491-4499
23. Caro JF, Amatruda JM. Insulin receptors in hepatocytes: postreceptor events mediate down regulation. Science 1980;210:1029-1031
24. Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 1982;31:883-889
25. Stagner JI, Samols E. The vascular order of islet cellular perfusion in the human pancreas. Diabetes 1992;41:93-97
26. Bonner-Weir S. Morphological evidence for pancreatic polarity of β-cell within islets of Langerhans. Diabetes 1988;37:616-621
27. Shapiro ET, Tillil H, Miller MA, et al. Insulin secretion and clearance. Comparison after oral and intravenous glucose. Diabetes 1987;36:1365-1371
28. Rhodes CJ, Halban PA. Newly synthesized proinsulin/insulin and stored insulin are released form pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol 1987;105:145-153
29. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans. Endocr Rev 1981;2:471-494
30. Duttaroy A, Zimliki CL, Gautam D, Cui Y, Mears D, Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 2004;53:1714- 1720
31. Winzell MS, Ahrén B. Role of VIP and PACAP in islet function. Peptides 2007;28:1805-1813
32. Porte D. Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch Intern Med 1969;123:252-260
33. Gregg BE, Moore PC, Demozay D, et al. Formation of a human β-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab 2012;97:3197-3206
34. Rodriguez-Diaz R, Abdulreda MH, Formoso AL, et al. Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 2011;14: 45-54
35. Stagner J, Samols E, Polonsky K, Pugh W. Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas. J Clin Invest 1986;78:1193-1198
36. Elahi D, Nagulesparan M, Hershcopf RJ, et al. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 1982;306:1196-1202
37. Boden G, Chen X, DeSantis R, Kolaczynski J, Morris M. Evidence that suppression of insulin secretion by insulin itself is neurally mediated. Metabolism 1993;42:786-789
38. Bouche C, Lopez X, Fleischman A, et al. Insulin enhances glucosestimulated insulin secretion in healthy humans. Proc Natl Acad Sci USA 2010;107:4770-4775
39. Halperin F, Lopez X, Manning R, Kahn CR, Kulkarni RN, Goldfine AB. Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans. Diabetes 2012;61:301-309
40. Vahl TP, Tauchi M, Durler TS, et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007; 148:4965-4973
41. Ionut V, Liberty IF, Hucking K, et al. Exogenously imposed postprandiallike rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. Am J Physiol Endocrinol Metab 2006;291:E779-E785
42. Imai J, Katagiri H, Yamada T, et al. Regulation of pancreatic beta cell mass by neuronal signals from the liver. Science 2008;322:1250-1254
43. Lausier J, Diaz WC, Roskens V, et al. Vagal control of pancreatic ß-cell proliferation. Am J Physiol Endocrinol Metab 2010;299:E786-E793
44. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte DJ Jr. Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 1992;13: 387-414
45. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999;96:329-339
46. Kulkarni RN, Holzenberger M, Shih DQ, et al. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 2002;31:111-115
47. Ueki K, Okada T, Hu J, et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat Genet 2006;38:583-588
48. Wicksteed B, Brissova M, Yan W, et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 2010;59:3090-3098
49. Song J, Xu Y, Hu X, Choi B, Tong Q. Brain expression of Cre recombinase driven by pancreas-specific promoters. Genesis 2010;48:628-634
50. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, Hennighausen L. RIPCre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem 2006;281:2649-2653
51. Schwartz MW, Guyenet SJ, Cirulli V. The hypothalamus and ß-cell connection in the gene-targeting era. Diabetes 2010;59:2991-2993
52. Best CH, Haist RE. The effect of insulin administration on the insulin content of the pancreas. J Physiol 1941;100:142-146
53. Giddings SJ, Chirgwin J, Permutt MA. The effects of fasting and feeding on preproinsulin messenger RNA in rats. J Clin Invest 1981;67:952-960
54. Halban PA, Wollheim CB. Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. J Biol Chem 1980;255:6003-6006
55. Giddings SJ, Chirgwin J, Permutt MA. Effects of glucose on proinsulin messenger RNA in rats in vivo. Diabetes 1982;31:624-629
56. Koranyi L, James DE, Kraegen EW, Permutt MA. Feedback inhibition of insulin gene expression by insulin. J Clin Invest 1992;89:432-436
57. Permutt MA, Kakita K, Malinas P, et al. An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes. J Clin Invest 1984;73:1344-1350
58. Jonas JC, Sharma A, Hasenkamp W, et al. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 1999;274:14112-14121
59. Wicksteed BL, Alarcón C, Briaud I, Dickson L, Lingohr MK, Rhodes CJ. Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet beta-cells but not regulated via a positive feedback of secreted insulin. J Biol Chem 2003;278:42080- 42090
60. Uchizono Y, Alarcón C, Wicksteed BL, Marsh BJ, Rhodes CJ. The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead? Diabetes Obes Metab 2007;9(Suppl. 2):56-66
61. Leibowitz G, Oprescu AI, Uçkaya G, Gross DJ, Cerasi E, Kaiser N. Insulin does not mediate glucose stimulation of proinsulin biosynthesis. Diabetes 2003;52:998-1003
62. Leibiger B, Wahlander K, Berggren PO, Leibiger IB. Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 2000;275:30153-30156
63. Luciani DS, Johnson JD. Acute effects of insulin on beta-cells from transplantable human islets. Mol Cell Endocrinol 2005;241:88-98
64. Cornu M, Yang JY, Jaccard E, Poussin C, Widmann C, Thorens B. Glucagonlike peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop. Diabetes 2009;58: 1816-1825